[Inequity in infant vaccination coverage in Colombia 2000 and 2003].

Rev Salud Publica (Bogota)

Salud Pública Centro de Proyectos para el Desarrollo-Cendex-, Pontificia Universidad Javeriana, Bogotá, Colombia.

Published: May 2006

Objective: Identifying inequity in childhood vaccination coverage in towns throughout Colombia for both immunisations scheme and type of vaccine.

Methods: An ecological study using secondary information for 2000 and 2003. Three indicators were measured: (1) gaps in coverage (understood as being the differences between municipal coverage and that at national level), (2) Gini coefficient and (3) Lorenz's curve.

Results: Decreasing national vaccination coverage was found, dropping from 78.8% in 2000 to 66.8% in 2003. The number of towns having gaps in their coverage also increased during the two years being studied. Vaccination coverage concentration coefficients and curves showed inequalities between the municipalities during the two years being studied, although Gini coefficients improved from 0.18 to 0.13 for vaccination coverage between 2000 and 2003. The anti-influenza vaccine had the greatest decrease in inequality during the years being studied, followed by the anti-hepatitis B vaccine. The smallest change was recorded for the tuberculosis vaccine (BCG). Poliovirus vaccine estimations lay between those for BCG and hepatitis B.

Conclusions: Action should be focused on municipalities identified as having recurring low coverage and large gaps compared to the national level.

Download full-text PDF

Source

Publication Analysis

Top Keywords

vaccination coverage
20
years studied
12
coverage
9
2000 2003
8
gaps coverage
8
national level
8
vaccination
5
[inequity infant
4
infant vaccination
4
coverage colombia
4

Similar Publications

HPV vaccine hesitancy in the United States.

Curr Opin Pediatr

January 2025

Section of Hospital Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.

Purpose Of Review: Human papillomavirus (HPV) is the most common STI and accounts for roughly 37 000 HPV-associated cancers annually in the United States. Despite documented safety and effectiveness of the HPV vaccine, vaccination rates should be higher. We summarize literature surrounding vaccine hesitancy, a main reason for suboptimal vaccine coverage.

View Article and Find Full Text PDF

Background: Research on long COVID in China is limited, particularly in terms of large-sample epidemiological data and the effects of recent SARS-CoV-2 sub-variants. China provides an ideal study environment owing to its large infection base, high vaccine coverage, and stringent pre-pandemic measures.

Methods: This retrospective study used an online questionnaire to investigate SARS-CoV-2 infection status and long COVID symptoms among 74,075 Chinese residents over one year.

View Article and Find Full Text PDF

Population-level Impact of HPV Vaccination on the Incidence of Genital Warts in Sweden.

J Infect Dis

January 2025

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12A, SE-17177 Stockholm, Sweden.

Background: Sweden introduced HPV vaccination in 2006, administered through opportunistic, subsidized, catch-up and school-based programs. Notably, genital warts (GW) are the first observable clinical outcome following infection by HPV-6/11, targeted by vaccination. We aim to gain knowledge of the incidence of GW in Sweden and evaluate its change throughout vaccination programs.

View Article and Find Full Text PDF

The politicisation of vaccines and its influence on Brazilian caregivers' opinions on childhood routine vaccination.

Cien Saude Colet

January 2025

Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo. São Paulo SP Brasil.

Progressive declines in vaccination coverage have been recorded in Brazil in recent years. The COVID-19 pandemic has introduced even more challenges to this scenario. Considering the pandemic as an event, the scope of this article was to analyze the politicization of vaccines from the perspective of caregivers of young children.

View Article and Find Full Text PDF

Longterm efficacy of a patient focused intervention in patients with asplenia- a three year follow-up of the PrePPS trial.

Infection

January 2025

Division of Infectious Diseases, Department of Medicine II, Medical Centre, Faculty of Medicine, University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.

Objectives: This study aimed to reassess the long-term impact of a Health Action Process Approach (HAPA)-informed intervention on guideline adherence among asplenic patients and their physicians, three years post-intervention.

Methods: This follow-up study was conducted within the framework of the interventional PrePSS (Prevention of Postsplenectomy Sepsis Score) study. Patients aged 18 or older with anatomical asplenia were in enrolled in a prospective controlled, two-armed historical control group design.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!